CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT SECRETS

Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors while in the central anxious process, conolidine modulates alternate molecular targets. A Science Innovations analyze discovered that conolidine interacts With all the atypical chemokine receptor ACKR3/C